News | January 31, 2008

Heart Disease Ranked Most Expensive of Top 10 Health Conditions

February 4, 2008 - Heart conditions cost $76 billion to treat in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

The nation’s 10 most expensive medical conditions costs totaled an estimated $500 billion to treat in 2005, said the survey. This includes money paid for visits to doctor's offices, clinics and emergency departments, hospital stays, home health care and prescription medicines.

Estimated spending for the 10 most expensive conditions:
1. Heart conditions $76 billion
2. Trauma disorders $72 billion
3. Cancer $70 billion
4. Mental disorders, including depression $56.0 billion
5. Asthma and chronic obstructive pulmonary disease $54 billion
6. High blood pressure $42 billion
7. Type 2 diabetes $34 billion
8. Osteoarthritis and other joint diseases $34 billion
9. Back problems $32 billion
10.Normal childbirth $32 billion

AHRQ, which is part of the U.S. Department of Health and Human Services, works to enhance the quality, safety, efficiency and effectiveness of health care in the United States. The data in this AHRQ News and Numbers summary are taken from the Medical Expenditure Panel Survey, a detailed source of information on the health services used by Americans, the frequency with which they are used, the cost of those services and how they are paid.

For more information: www.ahrq.org


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now